Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

It Takes Two to Tangle: Wistar Scientists Further Unravel Telomere Biology

Published: Friday, November 23, 2012
Last Updated: Friday, November 23, 2012
Bookmark and Share
Chromosomes are capped at their ends with special DNA structures called telomeres and an assortment of proteins, which together act as a protective sheath.

Telomeres are maintained through the interactions between an enzyme, telomerase, and several accessory proteins. Researchers at The Wistar Institute have defined the structure of one of these critical proteins in yeast.

Understanding how telomeres keep chromosomes–and by extension, genomes–intact is an area of intense scientific focus in the fields of both aging and cancer. In aging, the DNA of telomeres eventually erodes faster than telomerase and its accessory proteins can maintain it, and cells die. In cancer, tumor cells hijack the process, subverting the natural method by which our bodies limit cell growth; cancer cells, then, can grow and multiply unchecked.

One of these accessory proteins, Cdc13, is integral to telomere maintenance and essential for cell viability in yeast, according to researchers at The Wistar Institute. In a study published in the journal Structure, available online now, a team of scientists led by Emmanuel Skordalakes, Ph.D., an associate professor in The Wistar Institute Cancer Center’s Gene Expression and Regulation Program, has determined how mutations in a particular region of Cdc13 can lead to defects in telomeres that could jeopardize DNA.

Cdc13 normally functions as a matched-set, where two copies of the protein form what is known as a dimer. Skordalakes found that mutations in a region of Cdc13 (called OB2) prevent Cdc13 copies from binding to each other. The findings help explain the biology of this key telomere maintenance protein, and may eventually lead to novel anticancer therapeutic if their findings translate to a similar molecular system used to maintain human telomeres, Skordalakes says.

“If we could target the OB2 region of Cdc13, for example, it would throw a wrench in the works of telomere maintenance,” said Skordalakes. “If you can disrupt recruitment of telomerase in humans, you could potentially drive cells to death.”

Cdc13 serves a dual function in telomere replication. First, it keeps the cells’ natural DNA repair mechanisms from mistaking the telomere for a broken stretch of DNA, which could cause genetic mayhem if such repair proteins fuse the ends of two chromosomes together, for example. Secondly, Cdc13 recruits telomerase and related proteins to place in order to lengthen the telomeres.

In yeast, telomeres are decorated by a multi-protein complex called CST, which contains the proteins Cdc13 (C), Stn1 (S), and Ten1 (T). Cdc13 is a key member of that complex and serves both to cap the telomere structure and recruit key enzymes.

Skordalakes’ newly determined structure demonstrates that, like three of the other four regions of Cdc13, OB2 adopts what is called an oligonucleotide/oligosaccharide-binding fold (OB). These folds normally allow proteins to bind DNA or sugars, but OB2 does neither; its crystal structure indicates that this fold actually forms a large binding surface that helps two Cdc13 proteins to form a dimeric complex.

The authors then used biochemical analyses to determine that OB2 also does not directly bind the protein Stn1. Nevertheless, full-length Cdc13 OB2 mutants deficient in dimerization are also deficient in Stn1 recruitment. When the team inserted strategic Cdc13 mutations into yeast, they found that the cells had abnormally long telomeres, probably as a result of disrupted CST complex assembly caused by impaired Cdc13 dimerization.

“The dimerization of OB2 is required for the proper assembly of the CST complex at the telomeres,” Skordalakes says. “When you disrupt oligomerization of this domain, you disrupt assembly of this complex, and thus regulation of telomere length.”

The study was funded by the Pennsylvania Department of Health, the V Foundation, the Emerald Foundation, the National Institutes of Health, and the National Institute on Aging.

Co-authors include Sandy Harper, David Schultz, Ph.D., and David Speicher, Ph.D., from The Wistar Institute; and Mark Mason, Jennifer Wanat, Ph.D., and F. Brad Johnson, M.D., Ph.D., from the University of Pennsylvania School of Medicine.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Friday, November 04, 2016
Proteins Preserve Vital Genetic Data
Research has shown how two key proteins bring about the oragnization of chromosomes and our genome.
Wednesday, August 24, 2016
New Insight into Pre-Birth Cancer Development
Cells responsible for the development of leukaemia in the womb have been identified, adding to knowledge of this aggressive cancer type.
Friday, July 08, 2016
Graham Cancer Center, The Wistar Institute Partner
Partnership aims to accelerate breakthrough cancer research in the human genome.
Thursday, June 30, 2016
Aging Impacts Therapeutic Response of Melanoma Cells
Researchers at Wistar Institute have showed that tumor cells in aged skin behave differently than tumor cells in younger skin.
Friday, April 08, 2016
Genetic Variant and Bacteria Help Dictate Inflammation, Antitumor Activity, and Outcome in Cancer Patients
Research reveals more about the role the symbiotic relationship humans have with bacteria may play in tumor progression.
Monday, December 22, 2014
Wistar Scientists Decipher Structure of NatA, an Enzyme Complex that Modifies Most Human Proteins
A team of researchers has determined the structure of an enzyme complex that modifies one end of most human proteins and is made at elevated levels in numerous forms of cancer.
Wednesday, August 07, 2013
“Activating” RNA Takes DNA on a Loop through Time and Space
Long segments of RNA are key to physically manipulating DNA in order to activate certain genes, say researchers at The Wistar Institute.
Wednesday, February 20, 2013
Scientists Solve Structure of Gene Regulator that Plays Key Role in Cancer
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans.
Friday, February 15, 2008
Telomerase Enzyme Structure Provides Significant New Target for Anti-Cancer Therapies
Findings made by researchers at The Wistar Institute may also provide insights into normal aging.
Thursday, November 15, 2007
Study Details Regulation of Vital Tumor Suppressor Gene p53
Related modifications at single DNA site seen to have contradictory effects.
Friday, September 07, 2007
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Personality Traits, Psychiatric Disorders Linked to Specific Genomic Locations
Researchers have unearthed genetic correlations between personality traits and psychiatric disorders.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Gene-Editing Improves Vision in Blind Rats
Scientists developed a targeted gene-replacement technique that can modify genes in both dividing and non-dividing cells in living animals.
Gene Editing Yields Tomatoes That Ripen Weeks Earlier
Research team develop method to make tomato plants flower and ripen fruit two weeks faster than current growth rates.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Unexpected Role for Epigenetic Enzymes in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!